Protein and energy metabolism in type 1 diabetes

Clinical Nutrition

Volumn 29, Issue 1, 2010, Pages 13-17

  Hebert, Sadie L ^a   Nair, K Sreekumaran ^a  

^a MAYO CLINIC   (United States)

Author keywords

Energy metabolism; Insulin; Mitochondria; Protein synthesis; Type 1 diabetes

Indexed keywords

GLUCAGON; INSULIN; LEUCINE; MITOCHONDRIAL PROTEIN;

DRUG DOSE COMPARISON; DRUG MEGADOSE; ENERGY EXPENDITURE; ENERGY METABOLISM; ETHNICITY; GLUCAGON BLOOD LEVEL; HUMAN; HYPERGLUCAGONEMIA; INDIAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; LEUCINE OXIDATION; LOW DRUG DOSE; MITOCHONDRION; MITOCHONDRION ATP PRODUCTION RATE; OXIDATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE;

ASIA; BASAL METABOLISM; DIABETES MELLITUS, TYPE 1; ENERGY METABOLISM; HUMANS; PROTEINS;

EID: 75949129400     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.09.001     Document Type: Review

References (32)

1. Charlton M.R., Nair K.S. Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes 1998, 47(11):1748-1756.
2. Karakelides H., Asmann Y.W., Bigelow M.L., Short K.R., Dhatariya K., Coenen-Schimke J., et al. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 2007, 56(11):2683-2689.
3. Nair K.S., Halliday D., Garrow J.S. Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia 1984, 27(1):13-16.
4. Chhibber V.L., Soriano C., Tayek J.A. Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans. Metabolism 2000, 49(1):39-46.
5. Nair K.S. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency. J Clin Endocrinol Metab 1987, 64(5):896-901.
6. Nair K.S., Ford G.C., Ekberg K., Fernqvist-Forbes E., Wahren J. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 1995, 95(6):2926-2937.
7. Nair K.S., Garrow J.S., Ford C., Mahler R.F., Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983, 25(5):400-403.
8. Welle S., Nair K.S. Relationship of resting metabolic rate to body composition and protein turnover. Am J Physiol 1990, 258(6 Pt 1):E990-E998.
9. Stump C.S., Short K.R., Bigelow M.L., Schimke J.M., Nair K.S. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 2003, 100(13):7996-8001.
10. Boirie Y., Short K.R., Ahlman B., Charlton M., Nair K.S. Tissue-specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 2001, 50(12):2652-2658.
11. Takahashi M., Hood D.A. Protein import into subsarcolemmal and intermyofibrillar skeletal muscle mitochondria. Differential import regulation in distinct subcellular regions. J Biol Chem 1996, 271(44):27285-27291.
12. Wolfe R.R., Chinkes D.L. Whole body protein synthesis and breakdown. Isotope tracers in metabolic research: principles and practice of kinetic analysis 2005, John Wiley & Sons, Hoboken, New Jersey.
13. Nair K.S., Halliday D., Matthews D.E., Welle S.L. Hyperglucagonemia during insulin deficiency accelerates protein catabolism. Am J Physiol 1987, 253(2 Pt 1):E208-E213.
14. Tessari P., Inchiostro S., Barazzoni R., Zanetti M., Vettore M., Biolo G., et al. Hyperglucagonemia stimulates phenylalanine oxidation in humans. Diabetes 1996, 45(4):463-470.
15. Charlton M.R., Adey D.B., Nair K.S. Evidence for a catabolic role of glucagon during an amino acid load. J Clin Invest 1996, 98(1):90-99.
16. Tessari P., Iori E., Vettore M., Zanetti M., Kiwanuka E., Davanzo G., et al. Evidence for acute stimulation of fibrinogen production by glucagon in humans. Diabetes 1997, 46(8):1368-1371.
17. De Feo P., Gaisano M.G., Haymond M.W. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 1991, 88(3):833-840.
18. Charlton M., Nair K.S. Protein metabolism in insulin-dependent diabetes mellitus. J Nutr 1998, 128(2 Suppl):323S-327S.
19. Louard R.J., Barrett E.J., Gelfand R.A. Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin Sci (Lond) 1990, 79(5):457-466.
20. Nair K.S., Schwartz R.G., Welle S. Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. Am J Physiol 1992, 263(5 Pt 1):E928-E934.
21. Nygren J., Nair K.S. Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 2003, 52(6):1377-1385.
22. Nair K.S., Welle S.L., Halliday D., Campbell R.G. Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans. J Clin Invest 1988, 82(1):198-205.
23. Nair K.S., Ford G.C., Halliday D. Effect of intravenous insulin treatment on in vivo whole body leucine kinetics and oxygen consumption in insulin-deprived type I diabetic patients. Metabolism 1987, 36(5):491-495.
24. Meek S.E., Persson M., Ford G.C., Nair K.S. Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 1998, 47(12):1824-1835.
25. Jaleel A., Nehra V., Persson X.M., Boirie Y., Bigelow M., Nair K.S. In vivo measurement of synthesis rate of multiple plasma proteins in humans. Am J Physiol Endocrinol Metab 2006, 291(1):E190-E197.
26. Jaleel A., Short K.R., Asmann Y.W., Klaus K.A., Morse D.M., Ford G.C., et al. In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins. Am J Physiol Endocrinol Metab 2008, 295(5):E1255-E1268.
27. Nair K.S., Bigelow M.L., Asmann Y.W., Chow L.S., Coenen-Schimke J.M., Klaus K.A., et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 2008, 57(5):1166-1175.
28. Toledo F.G., Menshikova E.V., Azuma K., Radikova Z., Kelley C.A., Ritov V.B., et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 2008, 57(4):987-994.
29. Petersen K.F., Dufour S., Feng J., Befroy D., Dziura J., Dalla Man C., et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006, 103(48):18273-18277.
30. Petersen K.F., Shulman G.I. Etiology of insulin resistance. Am J Med 2006, 119(5 Suppl. 1):S10-S16.
31. Asmann Y.W., Stump C.S., Short K.R., Coenen-Schimke J.M., Guo Z., Bigelow M.L., et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006, 55(12):3309-3319.
32. Halvatsiotis P., Short K.R., Bigelow M., Nair K.S. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002, 51(8):2395-2404.